Antibodies to Shiga toxin in the serum of children with Shigella-associated haemolytic uraemic syndrome

Journal of Medical Microbiology

Volumn 48, Issue 1, 1999, Pages 11-16

  Azim, T ^a   Rashid, A ^b   Qadri, F ^a   Sarker, M S ^a   Hamadani, J ^a   Salam, M A ^a   Wahed, M A ^a   Albert, M J ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; SHIGA TOXIN; SHIGELLA ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REGRESSION ANALYSIS; SHIGELLA DYSENTERIAE; SHIGELLOSIS;

EID: 0033063322     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-1-11     Document Type: Article

References (25)

1. 1. Rahaman MM, Jamial Alam AKM, Islam MR. Greenough WB. Shiga bacillus dysentery associated with marked leukocytosis and erythrocyte fragmentation. Johns Hopkins Med J 1975; 136: 65-70.
2. 2. Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytoxin-producing Escherichia coli in stools. Lancet 1983; 1: 619-620.
3. 3. Acheson DWK, Levine MM, Kaper JB, Keusch GT. Protective immunity to Shiga-like toxin 1 following oral immunization with Shiga-like toxin 1 B subunit-producing Vibrio cholerae CVD 103-HgR. Infect Immun 1996; 64: 355-357.
4. 4. Louise CB, Obrig TG. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 1992; 60: 1536-1543.
5. 5. Obrig TG, Del Vecchio PJ, Brown JE et al. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 1988; 56: 2373-2378.
6. 6. Pulimood A, Koshi R, Date A, Mathan M. A murine model for haemolytic uremic syndrome, abstr. V105/V. In: VTEC '97 3rd International Symposium and Workshop on Shiga Toxin (Verocytotoxin) Producing Escherichia coli Infections, 1997: Baltimore, MD, USA, p. 86.
7. 7. Caprioli A, Luzzi I, Rosmini E et al. Hemulytic-uremic syndrome and vero cytotoxin-producing Escherichia coli infection in Italy. J Infect Dis 1992; 166: 154-158.
8. 8. Karmali MA, Petric M, Winkler M et al. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli vero cytotoxin I. J Clin Microbiol 1994; 32: 1457-1463.
9. 9. Lopez EL, Diaz M, Grinstein S et al. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis 1989; 160: 469-475.
10. 10. Yamada S, Kai A, Kudoh Y. Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Encherichia coli infections in patients with hemolytic-uremic syndrome. J Clin Microbiol 1994; 32: 955-959.
11. 11. Greatorex JS, Thorne GM. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects. J Clin Microbiol 1994; 32: 1172-1178.
12. 12. Ashkenazi S, Cleary TG, Lopez E, Pickering LK. Anti-cytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome. J Pediatr 1988; 113: 1008-1014.
13. 13. Sheth KJ, Gill JC, Leichter HE. High-dose intravenous gamma globulin infusions in hemolytic-uremic syndrome: a preliminary report. Am JDis Child 1990; 144: 268-270.
14. 14. Havens PL, Dunne WM, Burd EM. Effects of human intravenous globulin on diarrhoea caused by Shiga-like toxin I and Shiga-like toxin II in infant rabbits. Microbiol Immunol 1992; 36: 1077-1085.
15. 15. Keusch GT, Acheson DWK, McIver J, Kaper JB. Active and passive immunoprophylaxis for thrombotic microangiopathy secondary to infection with Shiga toxin-producing Escherichia coli (Abstract) In: The thirty-second joint conference US-Japan co-operative Medical Science Program, Cholera and related diarrheal diseases panel, 1996, Nagasaki, Japan. p. 119.
16. 16. Islam D, Wretlind B, Ryd M, Lindberg AA, Christensson B. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis. Infect Immun 1995; 63: 2054-2061.
17. 17. Islam D, Wretlind B, Hammarström L, Christensson B, Lindberg AA. Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis. APMIS 1996; 104: 563-574.
18. 18. World Health Organization. Manual for laboratory investigations of acute enteric infections. Geneva, World Health Organization. 1987: 9-20.
19. 19. Donohue-Rolfe A, Acheson DWK, Kane AV, Keusch GT. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized PI glycoprotein and production of cross-reactive monoclonal antibodies. Infect Immun 1989; 57: 3888-3893.
20. 20. Qadri F, Mohi MG, Azim T, Faruque SM, Qadri SS, Albert MJ. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin. J Diarrhoeal Dis Res 1996; 14: 95-100.
21. 21. Downes FP, Green JH, Greene K, Stroekbine N, Wells JG, Wachsmuth IK. Development and evaluation of enzyme-linked immunosorbent assays for detection of Shiga-like toxin I and Shiga-like toxin II. J Clin Microbiol 1989; 27: 1292-1297.
22. 22. Azim T, Qadri F, Ahmed S et al. Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome. Clin Diagn Lab Immunol 1996; 3: 701-705.
23. 23. Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis. J Clin Pathol 1997; 50: 513-520.
24. 24. Cohen A, Madrid-Marina V, Estrov Z, Freedman MH, Lingwood CA, Dosch H-M. Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int Immunol 1990; 2: 1-8.
25. 25. DeSilva DGH, Mendis LN, Sheron N et al. Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut 1993; 34: 194-198.